Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide

This report highlights zonisamide as a potential cause of serious cutaneous reactions as well as its cross‐reactivity with other sulfonamides. Here, we present a case of SJS‐TEN due to zonisamide, which was effectively treated with IVIg. Subsequently, the patient was transitioned to levetiracetam fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivar, Karina L., Mancl, Kimberly, Seminario‐Vidal, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799627/
https://www.ncbi.nlm.nih.gov/pubmed/29445458
http://dx.doi.org/10.1002/ccr3.1288
_version_ 1783298038049013760
author Vivar, Karina L.
Mancl, Kimberly
Seminario‐Vidal, Lucia
author_facet Vivar, Karina L.
Mancl, Kimberly
Seminario‐Vidal, Lucia
author_sort Vivar, Karina L.
collection PubMed
description This report highlights zonisamide as a potential cause of serious cutaneous reactions as well as its cross‐reactivity with other sulfonamides. Here, we present a case of SJS‐TEN due to zonisamide, which was effectively treated with IVIg. Subsequently, the patient was transitioned to levetiracetam for seizure control.
format Online
Article
Text
id pubmed-5799627
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57996272018-02-14 Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide Vivar, Karina L. Mancl, Kimberly Seminario‐Vidal, Lucia Clin Case Rep Case Reports This report highlights zonisamide as a potential cause of serious cutaneous reactions as well as its cross‐reactivity with other sulfonamides. Here, we present a case of SJS‐TEN due to zonisamide, which was effectively treated with IVIg. Subsequently, the patient was transitioned to levetiracetam for seizure control. John Wiley and Sons Inc. 2017-12-20 /pmc/articles/PMC5799627/ /pubmed/29445458 http://dx.doi.org/10.1002/ccr3.1288 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Vivar, Karina L.
Mancl, Kimberly
Seminario‐Vidal, Lucia
Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title_full Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title_fullStr Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title_full_unstemmed Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title_short Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide
title_sort stevens–johnson syndrome/toxic epidermal necrolysis associated with zonisamide
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799627/
https://www.ncbi.nlm.nih.gov/pubmed/29445458
http://dx.doi.org/10.1002/ccr3.1288
work_keys_str_mv AT vivarkarinal stevensjohnsonsyndrometoxicepidermalnecrolysisassociatedwithzonisamide
AT manclkimberly stevensjohnsonsyndrometoxicepidermalnecrolysisassociatedwithzonisamide
AT seminariovidallucia stevensjohnsonsyndrometoxicepidermalnecrolysisassociatedwithzonisamide

Ejemplares similares